San Francisco, CA, United States of America

Vikram Sharma

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vikram Sharma: Innovator in Antibody Development

Introduction

Vikram Sharma is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic and diagnostic applications. His work focuses on addressing medical conditions associated with marinobufagenin.

Latest Patents

Vikram Sharma holds a patent for "Anti-marinobufagenin antibodies and uses thereof." This patent provides chimeric, humanized, and human monoclonal antibodies (mAbs) that specifically bind to marinobufagenin (MBG) with high affinity. The anti-MBG mAbs can be utilized to treat MBG-associated disorders, including hypertensive and fibrotic disorders, often in combination with additional therapeutic agents. Furthermore, these antibodies can be employed for diagnostic purposes, such as detecting MBG in biological samples and diagnosing related disorders.

Career Highlights

Throughout his career, Vikram has worked with various companies, including Cts Biopharma LLC and Integrigen, Inc. His experience in these organizations has contributed to his expertise in antibody development and therapeutic applications.

Collaborations

Vikram has collaborated with notable professionals in the field, including James W. Larrick and John M. Wages. These collaborations have further enhanced his research and development efforts in biotechnology.

Conclusion

Vikram Sharma is a distinguished inventor whose work in antibody development has the potential to impact the treatment and diagnosis of various medical conditions. His innovative contributions continue to advance the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…